SEC Form 4 · accession 0001140361-15-034124
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne Reiser
Officer — President - ResMed Europe
Period of report
Aug 28, 2015
Accepted (ET)
Sep 1, 2015 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Aug 28, 2015 | M | 6,000 | $17.30 | A | 89,214 | D | |
| ResMed Common StockF1 | Aug 28, 2015 | S | 6,000 | $52.264 | D | 83,214 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Options | $17.30 | Aug 28, 2015 | M | 6,000 | A | Nov 24, 2012 | Nov 24, 2015 | ResMed Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $52.21 to $52.30. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.